Prostate-specific antigen kinetics in localized and advanced prostate cancer

Area of Science:

• Urology
• Oncology
• Biochemistry

Background:

• Prostate cancer management relies on early detection, risk assessment, and treatment.
• Prostate-specific antigen (PSA) has been a key serum marker for prostate cancer since the 1980s.
• Despite its widespread use, PSA has limitations in specificity and sensitivity, leading to controversies in its diagnostic application.

Purpose of the Study:

• To review the added value of PSA kinetics compared to single PSA measurements.
• To assess the role of PSA kinetics in the early detection of prostate cancer.
• To evaluate PSA kinetics in predicting outcomes for localized and advanced prostate cancer.

Main Methods:

• Review of publications on PSA kinetics.
• Comparison of PSA kinetics with single PSA measurements.
• Analysis of PSA kinetics for early detection and outcome prediction.

Main Results:

• Single PSA measurements have limitations in specificity, sensitivity, and distinguishing cancer aggressiveness.
• PSA kinetics show considerable promise in enhancing the diagnostic and prognostic value of PSA testing.
• Further research and ongoing studies aim to clarify the impact of PSA screening on mortality rates.

Conclusions:

• PSA kinetics represent a significant advancement over single PSA measurements for prostate cancer management.
• Understanding PSA kinetics can improve early detection and patient outcome prediction.
• Continued research is essential to fully leverage PSA kinetics in clinical practice.